Mild illness at or after measles vaccination does not reduce seroresponse in young children

By Scott S.   Cutts F.T.   Nyandu B.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 837-843

Elsevier

Access to resources Recommend Favorite

Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection

By Cilla G.   Pena B.   Marimon J.M.   Perez-Trallero E.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 492-494

Elsevier

Access to resources Recommend Favorite

Characterization of measles viruses isolated after measles vaccination

By Kobune F.   Funatu M.   Takahashi H.   Fukushima M.   Kawamoto A.   Iizuka S.   Sakata H.   Yamazaki S.   Arita M.   Wenbo X.   Li-Bi Z.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 370-372

Elsevier

Access to resources Recommend Favorite

Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

By Boulianne N.   De Serres G.   Duval B.   Ratnam S.   Ward B.J.   Joly J.R.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1611-1616

Elsevier

Access to resources Recommend Favorite

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

By Miller E.   Rush M.   Hill A.   Morgan-Capner P.   Forsey T.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite